Fairvalue-Calculator Fairvalue-Calculator
EN DE

Caplin Point Laboratories Limited (CAPLIPOINT) Fair Value & Analysis

Healthcare · IN · Market cap ₹190B

Price₹2,506
Fair Value₹1,482
Upside-40.9%
Quality95/100
Evidence: High Range ₹1,043 – ₹3,211

Fair value as of: Jun 29, 2026

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

Caplin Point Laboratories Limited (CAPLIPOINT) currently trades at ₹2,506, while our model-based Fair Value estimate is ₹1,482 — implying the stock looks roughly 40.9% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic formulations and branded products in India. The company provides tablets, capsules, injections, ophthalmic, liquid orals, softgel capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag formulations, inhalers, and sprays and IV infusion. It also provides dry and syrups, lyophilized vials, prefilled syringes, emulsion injection, sachets, liquid injectables, topicals, pre-filled syringes, and pre-mix bags. Caplin Point Laboratories Limited was incorporated in 1990 and is headquartered in Chennai, India.

Open the full interactive analysis →

Similar stocks

Jiangsu Hengrui Pharmaceuticals Co (600276) -37% Sun Pharmaceutical Industries Limited (SUNPHARMA) -44% Zoetis Inc (Z1TS34) -1% Hansoh Pharmaceutical Group (3692) -37% Divi's Laboratories Limited (DIVISLAB) -70% Swedish Orphan Biovitrum AB (SOBI) -54%

Frequently asked questions

Is Caplin Point Laboratories Limited (CAPLIPOINT) undervalued?
As of Jun 29, 2026, our model estimates a fair value of ₹1,482 versus a price of ₹2,506 — about −41% (overvalued). Model-based estimate, not financial advice.
What is the fair value of CAPLIPOINT?
Our 21-model fair value for Caplin Point Laboratories Limited is ₹1,482 (as of Jun 29, 2026), built from audited fundamentals. The current price is ₹2,506.
What is the quality score of CAPLIPOINT?
Caplin Point Laboratories Limited has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.